Prime Medicine, Inc. (PRME) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$208.35M | -2.9% |
| 2024 | -$202.47M | +1.1% |
| 2023 | -$204.79M | -75.7% |
| 2022 | -$116.54M | -38.0% |
| 2021 | -$84.47M | -8963.7% |
| 2020 | -$932.0K | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$208.35M | -2.9% |
| 2024 | -$202.47M | +1.1% |
| 2023 | -$204.79M | -75.7% |
| 2022 | -$116.54M | -38.0% |
| 2021 | -$84.47M | -8963.7% |
| 2020 | -$932.0K | — |